Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $75.8200 (3.49%) ($75.8200 - $75.8200) on Thu. Jan. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.68% (three month average) | RSI | 47 | Latest Price | $75.8200(3.49%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IWC(58%) IBUY(57%) IWM(56%) | Factors Impacting EDIT price | EDIT will decline at least -3.84% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-13%) TBT(-7%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.84% (StdDev 7.68%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $77.02 | 5 Day Moving Average | $78.4(-3.29%) | 10 Day Moving Average | $78.06(-2.87%) | 20 Day Moving Average | $77.02(-1.56%) | To recent high | -16.6% | To recent low | 173.5% | Market Cap | $4.709b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |